|
Sign In to gain access to subscriptions and/or personal tools.
|
A Comparison of United Kingdom and Spanish General Population Time Trade-off Values for EQ-5D Health States
Xavier Badia, PhD
Catalan Institute of Public Health, Barcelona, Spain
Montserrat Roset, BSc
Catalan Institute of Public Health, Barcelona, Spain
Michael Herdman, MSc
Catalan Institute of Public Health, Barcelona, Spain
Paul Kind, PhD
Catalan Institute of Public Health, Barcelona, Spain
Few studies have compared preference values for health states obtained in different countries. The present study compared Spanish and United Kingdom (UK) time trade-off values for EuroQol-5D health states. The same preference elicitation protocol was followed in both countries. Differences in values for 43 health states rated directly were analyzed using t tests, and regression coefficients generated by random effects modeling were compared by aggregating the 2 value sets and using dummy variables to analyze country effect by dimension and level of severity. For the milder health states, Spanish and UK value assignation was similar; for intermediate health states, Spanish values were both higher and lower than UK values, whereas for health states worse than death, UK values were generally higher than Spanish values. There were statistically significant differences (P < 0.01) in values for 34.9% of health states rated directly, and some preference reversals between countries. UK raters ascribed greater importance to dimensions of pain/discomfort and anxiety/depression, whereas Spanish raters placed more importance on functional dimensions of mobility and self-care. Further analysis is required to determine how these differences affect cost-effectiveness and cost-utility analyses.
Key Words: EQ-5D health states preference values United Kingdom Spain comparison
Medical Decision Making, Vol. 21, No. 1,
7-16 (2001)
DOI: 10.1177/0272989X0102100102

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. U. Wittrup-Jensen, J. Lauridsen, C. Gudex, and K. M. Pedersen
Generation of a Danish TTO value set for EQ-5D health states
Scand J Public Health,
July 1, 2009;
37(5):
459 - 466.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zlowodzki, O. Brink, J. Switzer, S. Wingerter, J. Woodall Jr, B. A. Petrisor, P. J. Kregor, D. R. Bruinsma, and M. Bhandari
The effect of shortening and varus collapse of the femoral neck on function after fixation of intracapsular fracture of the hip: A MULTI-CENTRE COHORT STUDY
J Bone Joint Surg Br,
November 1, 2008;
90-B(11):
1487 - 1494.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Olivieri, S. de Portu, C. Salvarani, A. Cauli, E. Lubrano, A. Spadaro, F. Cantini, M. S. Cutro, A. Mathieu, M. Matucci-Cerinic, et al.
The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy
Rheumatology,
November 1, 2008;
47(11):
1664 - 1670.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Nan Luo, J. A. Johnson, J. W. Shaw, and S. J. Coons
A Comparison of EQ-5D Index Scores Derived from the US and UK Population-Based Scoring Functions
Med Decis Making,
May 1, 2007;
27(3):
321 - 326.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Lilford, A. Girling, D. Braunholtz, W. Gillett, J. Gordon, C. A. Brown, and A. Stevens
Cost-Utility Analysis When Not Everyone Wants the Treatment: Modeling Split-Choice Bias
Med Decis Making,
January 1, 2007;
27(1):
21 - 26.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Luo, Q. Wang, D. Feeny, G. Chen, S.-C. Li, and J. Thumboo
Measuring Health Preferences for Health Utilities Index Mark 3 Health States: A Study of Feasibility and Preference Differences among Ethnic Groups in Singapore
Med Decis Making,
January 1, 2007;
27(1):
61 - 70.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Lamers, P. F. M. Stalmeier, P. F. M. Krabbe, and J. J. V. Busschbach
Inconsistencies in TTO and VAS Values for EQ-5D Health States
Med Decis Making,
March 1, 2006;
26(2):
173 - 181.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Calvert, N. Freemantle, G. Yao, J. G.F. Cleland, L. Billingham, J.-C. Daubert, S. Bryan, and on behalf of the CARE-HF Investigators
Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial
Eur. Heart J.,
December 2, 2005;
26(24):
2681 - 2688.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Gringeri, L. G. Mantovani, L. Scalone, and P. M. Mannucci
Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group
Blood,
October 1, 2003;
102(7):
2358 - 2363.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|